JPM vs PROF · P/E 14, rev $182.45B vs rev $10.7M
JPMorgan Chase & Co (JPM) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
JPMorgan Chase & Co (JPM) is a banks - diversified company listed on US. It is led by Jamie Dimon.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported JPM revenue for 2025-12-31 was $182.45B. Net income was $57.05B. Revenue was up 2.8% from 2024-12-31 to 2025-12-31. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
JPM currently screens at market cap $805.69B and trailing P/E 14.2. PROF currently screens at market cap $238.7M.
Not investment advice. Open the JPM and PROF stock pages for the full models.
Not investment advice.